Renal involvement in children with HUS

Carla M. Nester, Sharon Andreoli

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Citations (Scopus)

Abstract

The thrombotic microangiopathies consist of a heterogeneous group of diseases which have common clinical manifestations including nonimmune hemolytic anemia, thrombocytopenia, and acute kidney injury. They also share in common endothelial cell injury and microthrombus formation as the central pathologic features (Fig. 1). While they share common clinical and pathologic manifestations, they have quite different and unique etiologies, presentations, pathogenesis, and therapies [1–6]. The most common cause of hemolytic uremic syndrome (HUS) is infectious agents with Shiga toxin-producing Escherichia coli (STEC) being the predominant cause of infectious HUS (Fig. 2). Atypical HUS (aHUS) can result from genetic mutations in complement regulatory proteins including complement factors H (FH), I (FI), and B (FB), as well as other factors. Thrombotic thrombocytopenia purpura (TTP) is caused by an inherited genetic mutation or an acquired immune deficiency in a disintegrin and metalloprotease with thrombospondin type 1 repeats 13 (ADAMTS13). ADAMTS13 cleaves von Willebrand factor (VWF) facilitating its release from endothelial cells, thereby preventing the accumulation of prothrombotic ultra-large VWF oligomers. Other less common causes of HUS include drug-induced HUS, cobalamin deficiency HUS, transplant-associated HUS, and other secondary causes of HUS such as systemic lupus erythematosus and malignant hypertension.

Original languageEnglish (US)
Title of host publicationPediatric Nephrology, Seventh Edition
PublisherSpringer Berlin Heidelberg
Pages1489-1521
Number of pages33
ISBN (Print)9783662435960, 9783662435953
DOIs
StatePublished - Jan 1 2015

Fingerprint

Hemolytic-Uremic Syndrome
Kidney
Thrombospondin 1
Disintegrins
von Willebrand Factor
Metalloproteases
Thrombocytopenia
Complement Factor I
Endothelial Cells
Thrombotic Microangiopathies
Malignant Hypertension
Shiga-Toxigenic Escherichia coli
Complement Factor H
Mutation
Complement Factor B
Purpura
Hemolytic Anemia
Vitamin B 12
Acute Kidney Injury
Systemic Lupus Erythematosus

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Nester, C. M., & Andreoli, S. (2015). Renal involvement in children with HUS. In Pediatric Nephrology, Seventh Edition (pp. 1489-1521). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-662-43596-0_43

Renal involvement in children with HUS. / Nester, Carla M.; Andreoli, Sharon.

Pediatric Nephrology, Seventh Edition. Springer Berlin Heidelberg, 2015. p. 1489-1521.

Research output: Chapter in Book/Report/Conference proceedingChapter

Nester, CM & Andreoli, S 2015, Renal involvement in children with HUS. in Pediatric Nephrology, Seventh Edition. Springer Berlin Heidelberg, pp. 1489-1521. https://doi.org/10.1007/978-3-662-43596-0_43
Nester CM, Andreoli S. Renal involvement in children with HUS. In Pediatric Nephrology, Seventh Edition. Springer Berlin Heidelberg. 2015. p. 1489-1521 https://doi.org/10.1007/978-3-662-43596-0_43
Nester, Carla M. ; Andreoli, Sharon. / Renal involvement in children with HUS. Pediatric Nephrology, Seventh Edition. Springer Berlin Heidelberg, 2015. pp. 1489-1521
@inbook{a875efa5fe974affb9b29b98fd8c9f94,
title = "Renal involvement in children with HUS",
abstract = "The thrombotic microangiopathies consist of a heterogeneous group of diseases which have common clinical manifestations including nonimmune hemolytic anemia, thrombocytopenia, and acute kidney injury. They also share in common endothelial cell injury and microthrombus formation as the central pathologic features (Fig. 1). While they share common clinical and pathologic manifestations, they have quite different and unique etiologies, presentations, pathogenesis, and therapies [1–6]. The most common cause of hemolytic uremic syndrome (HUS) is infectious agents with Shiga toxin-producing Escherichia coli (STEC) being the predominant cause of infectious HUS (Fig. 2). Atypical HUS (aHUS) can result from genetic mutations in complement regulatory proteins including complement factors H (FH), I (FI), and B (FB), as well as other factors. Thrombotic thrombocytopenia purpura (TTP) is caused by an inherited genetic mutation or an acquired immune deficiency in a disintegrin and metalloprotease with thrombospondin type 1 repeats 13 (ADAMTS13). ADAMTS13 cleaves von Willebrand factor (VWF) facilitating its release from endothelial cells, thereby preventing the accumulation of prothrombotic ultra-large VWF oligomers. Other less common causes of HUS include drug-induced HUS, cobalamin deficiency HUS, transplant-associated HUS, and other secondary causes of HUS such as systemic lupus erythematosus and malignant hypertension.",
author = "Nester, {Carla M.} and Sharon Andreoli",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-3-662-43596-0_43",
language = "English (US)",
isbn = "9783662435960",
pages = "1489--1521",
booktitle = "Pediatric Nephrology, Seventh Edition",
publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Renal involvement in children with HUS

AU - Nester, Carla M.

AU - Andreoli, Sharon

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The thrombotic microangiopathies consist of a heterogeneous group of diseases which have common clinical manifestations including nonimmune hemolytic anemia, thrombocytopenia, and acute kidney injury. They also share in common endothelial cell injury and microthrombus formation as the central pathologic features (Fig. 1). While they share common clinical and pathologic manifestations, they have quite different and unique etiologies, presentations, pathogenesis, and therapies [1–6]. The most common cause of hemolytic uremic syndrome (HUS) is infectious agents with Shiga toxin-producing Escherichia coli (STEC) being the predominant cause of infectious HUS (Fig. 2). Atypical HUS (aHUS) can result from genetic mutations in complement regulatory proteins including complement factors H (FH), I (FI), and B (FB), as well as other factors. Thrombotic thrombocytopenia purpura (TTP) is caused by an inherited genetic mutation or an acquired immune deficiency in a disintegrin and metalloprotease with thrombospondin type 1 repeats 13 (ADAMTS13). ADAMTS13 cleaves von Willebrand factor (VWF) facilitating its release from endothelial cells, thereby preventing the accumulation of prothrombotic ultra-large VWF oligomers. Other less common causes of HUS include drug-induced HUS, cobalamin deficiency HUS, transplant-associated HUS, and other secondary causes of HUS such as systemic lupus erythematosus and malignant hypertension.

AB - The thrombotic microangiopathies consist of a heterogeneous group of diseases which have common clinical manifestations including nonimmune hemolytic anemia, thrombocytopenia, and acute kidney injury. They also share in common endothelial cell injury and microthrombus formation as the central pathologic features (Fig. 1). While they share common clinical and pathologic manifestations, they have quite different and unique etiologies, presentations, pathogenesis, and therapies [1–6]. The most common cause of hemolytic uremic syndrome (HUS) is infectious agents with Shiga toxin-producing Escherichia coli (STEC) being the predominant cause of infectious HUS (Fig. 2). Atypical HUS (aHUS) can result from genetic mutations in complement regulatory proteins including complement factors H (FH), I (FI), and B (FB), as well as other factors. Thrombotic thrombocytopenia purpura (TTP) is caused by an inherited genetic mutation or an acquired immune deficiency in a disintegrin and metalloprotease with thrombospondin type 1 repeats 13 (ADAMTS13). ADAMTS13 cleaves von Willebrand factor (VWF) facilitating its release from endothelial cells, thereby preventing the accumulation of prothrombotic ultra-large VWF oligomers. Other less common causes of HUS include drug-induced HUS, cobalamin deficiency HUS, transplant-associated HUS, and other secondary causes of HUS such as systemic lupus erythematosus and malignant hypertension.

UR - http://www.scopus.com/inward/record.url?scp=84957621978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957621978&partnerID=8YFLogxK

U2 - 10.1007/978-3-662-43596-0_43

DO - 10.1007/978-3-662-43596-0_43

M3 - Chapter

AN - SCOPUS:84957621978

SN - 9783662435960

SN - 9783662435953

SP - 1489

EP - 1521

BT - Pediatric Nephrology, Seventh Edition

PB - Springer Berlin Heidelberg

ER -